Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India · Delayed Price · Currency is INR 13.99
-0.99 (-6.61%)
At close: Sep 22, 2026
BOM:531015 Market Cap
BOM:531015 has a market cap or net worth of 162.05 million as of September 22, 2026. Its market cap has increased by 17.16% in one year.
Market Cap
162.05M
Enterprise Value
155.93M
Revenue
92.94M
Ranking
n/a
PE Ratio
57.25
Stock Price
13.99
ChartMarket Cap Chart
Since April 15, 2008, BOM:531015's market cap has increased from 32.40M to 162.05M, an increase of 400.16%. That is a compound annual growth rate of 9.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 162.05M | 23.97% |
| Dec 31, 2025 | 130.71M | 38.30% |
| Dec 31, 2024 | 94.51M | 357.87% |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Panchsheel Organics | 1.47B |
| Kimia Biosciences | 1.39B |
| Krebs Biochemicals & Industries | 1.23B |
| Tyche Industries | 1.14B |
| Vasundhara Rasayans | 499.45M |
| Crestchem | 460.50M |
| Alfavision Overseas (India) | 418.35M |
| Bacil Pharma | 307.73M |